tert-Butylhydroquinone structure
|
Common Name | tert-Butylhydroquinone | ||
|---|---|---|---|---|
| CAS Number | 1948-33-0 | Molecular Weight | 166.217 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 291.4±20.0 °C at 760 mmHg | |
| Molecular Formula | C10H14O2 | Melting Point | 127-129 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 138.7±16.4 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of tert-ButylhydroquinoneTBHQ is an antioxidant that activates Nrf2. |
| Name | 2-tert-butylhydroquinone |
|---|---|
| Synonym | More Synonyms |
| Description | TBHQ is an antioxidant that activates Nrf2. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 291.4±20.0 °C at 760 mmHg |
| Melting Point | 127-129 °C(lit.) |
| Molecular Formula | C10H14O2 |
| Molecular Weight | 166.217 |
| Flash Point | 138.7±16.4 °C |
| Exact Mass | 166.099380 |
| PSA | 40.46000 |
| LogP | 2.33 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.545 |
| Stability | Stable. Incompatible with strong bases, strong oxidizing agents. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R22 |
| Safety Phrases | S26-S36-S28A |
| RIDADR | UN3077 |
| WGK Germany | 3 |
| RTECS | MX4375000 |
| Packaging Group | III |
| Hazard Class | 9 |
| HS Code | 29072900 |
| Precursor 10 | |
|---|---|
| DownStream 9 | |
| HS Code | 2907299090 |
|---|---|
| Summary | 2907299090 polyphenols; phenol-alcohols。supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward)。VAT:17.0%。tax rebate rate:9.0%。MFN tariff:5.5%。general tariff:30.0% |
|
Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells.
Br. J. Cancer 111(5) , 874-82, (2014) Standard therapy for acute promyelocytic leukaemia (APL) includes retinoic acid (all-trans retinoic acid (ATRA)), which promotes differentiation of promyelocytic blasts. Although co-administration of ... |
|
|
A method for long term stabilisation of long chain polyunsaturated fatty acids in dried blood spots and its clinical application.
Prostaglandins Leukot. Essent. Fatty Acids 91(6) , 251-60, (2014) Conventional assays of omega-3 long chain polyunsaturated fatty acid (n-3 LCPUFA) status in humans involve venous blood collection and expensive, multi-step processes that limit their usefulness as sc... |
|
|
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms.
Oncotarget 5(19) , 9118-32, (2014) Resistance to Imatinib mesylate (IM) is an emerging problem for patients with chronic myelogenous leukemia (CML). T315I mutation in the Bcr-Abl is the predominant mechanism of the acquired resistance ... |
| Hydroquinone,tert-butyl |
| 1,4-Benzenediol, 2-(1,1-dimethylethyl)- |
| 2-(1,1-dimethylethyl)benzene-1,4-diol |
| tert-Butylhydroquinone |
| TBHQ |
| 2-tert-Butylhydroquinone |
| Hydroquinone, t-butyl- |
| 2-tert-butyl-1,4-dihydroxybenzene |
| 2-(1,1-Dimethylethyl)-1,4-benzenediol |
| Hydroquinone, tert-butyl- |
| Butylhydroquinone, t- |
| 2-tert-Butyl-1,4-benzenediol |
| tert-Butylhydroquinone (TBHQ) |
| tert-butyl hydroquinone |
| MFCD00002344 |
| Butylhydroquinone, tert- |
| EINECS 217-752-2 |
| MTBHQ |
| 2-(2-Methyl-2-propanyl)-1,4-benzenediol |
| t-Butyl hydroquinone |
| 2-tert-butyl-hydroquinone |
| 2-tert-Butylbenzene-1,4-diol |
| Mono-tert-butylhydroquinone |
| 1-t-Butyl-1,4-dihydroxybenzene |
| 2-tertiary-butylhydroquinone |